Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Vincenzo Valentini
Affiliation
Universita Cattolica del Sacro Cuore
ORCID
Career Start Year
1983
Papers
701
H Index
56
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36318237
Multimodal locoregional procedures for cancer pain management: a literature review.
Br J Radiol
2023
37491564
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves.
Intern Emerg Med
2023
37218005
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis.
Radiat Oncol
2023
37150445
Are hybrid conferences the new standard?
Radiother Oncol
2023
36983788
Safety and Feasibility of Analgosedation for Electrochemotherapy of Liver Lesions.
Life (Basel)
2023
37444784
KIT 1 (Keep in Touch) Project-Televisits for Cancer Patients during Italian Lockdown for COVID-19 Pandemic: The Real-World Experience of Establishing a Telemedicine System.
Healthcare (Basel)
2023
37382176
Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge.
J Am Heart Assoc
2023
37312079
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
BMC Cancer
2023
37244324
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer.
Crit Rev Oncol Hematol
2023
37438740
The Italian version of the Pediatric Quality of Life Inventoryâ¿¢ (PEDSQLâ¿¢) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology.
Health Qual Life Outcomes
2023
37370819
pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials.
Cancers (Basel)
2023
37370692
Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer.
Cancers (Basel)
2023
37203844
Multiparametric imaging guided HDR interventional radiotherapy (brachytherapy) boost in localized prostate cancer: a multidisciplinary experience.
Eur Rev Med Pharmacol Sci
2023
37034335
GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research.
Front Cardiovasc Med
2023
37265796
A process mining approach for clinical guidelines compliance: real-world application in rectal cancer.
Front Oncol
2023
36965575
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up').
Ann Oncol
2023
36923954
Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial <i>via</i> matched pair analysis.
Front Cardiovasc Med
2023
36549470
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.
Clin Gastroenterol Hepatol
2023
36720505
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
Int J Gynecol Cancer
2023
36612304
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments.
Cancers (Basel)
2023
36935859
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group.
Clin Transl Radiat Oncol
2023
36566990
The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice.
Radiother Oncol
2023
36755901
Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives.
Front Public Health
2023
34155084
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD).
Int J Gynecol Cancer
2022
35680773
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study.
Radiol Med
2022
35480103
Dosimetric Impact of Inter-Fraction Variability in the Treatment of Breast Cancer: Towards New Criteria to Evaluate the Appropriateness of Online Adaptive Radiotherapy.
Front Oncol
2022
35652971
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.
Lung
2022
35585020
Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy.
Diagn Interv Imaging
2022
35406415
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.
Cancers (Basel)
2022
35503635
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1).
Eur Rev Med Pharmacol Sci
2022
35641417
Detection of parametrial invasion in women with uterine cervical cancer using diffusion tensor imaging at 1.5T MRI.
Diagn Interv Imaging
2022
35372704
Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery.
Phys Imaging Radiat Oncol
2022
35432777
Immunosuppressive treatment and radiotherapy in kidney transplant patients: A systematic review.
World J Radiol
2022
35396587
Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.O.
Acta Otorhinolaryngol Ital
2022
35600370
Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience.
Front Oncol
2022
35428267
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort.
Radiat Oncol
2022
35662658
A predictive nomogram for trismus after radiotherapy for head and neck cancer.
Radiother Oncol
2022
35454956
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?
Life (Basel)
2022
35450757
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis.
Eur J Surg Oncol
2022
35858537
Prediction of VMAT delivery accuracy using plan modulation complexity score and log-files analysis.
Biomed Phys Eng Express
2022
35355131
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
Ann Surg Oncol
2022
35811004
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Radiother Oncol
2022
36579601
Preoperative Tumor Texture Analysis on MRI for High-Risk Disease Prediction in Endometrial Cancer: A Hypothesis-Generating Study.
J Pers Med
2022
36431245
SUPeRO: A Multidimensional Approach to Prevent and Manage Oncological Frailty in a Radiation Oncology Unit.
J Clin Med
2022
36935855
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Clin Transl Radiat Oncol
2022
36497903
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis.
Int J Environ Res Public Health
2022
36632087
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription.
Adv Radiat Oncol
2022
36523999
Tuning the optimal diffusion-weighted MRI parameters on a 0.35-T MR-Linac for clinical implementation: A phantom study.
Front Oncol
2022
36143900
Assessment of Sexual Dysfunction in Cervical Cancer Patients after Different Treatment Modality: A Systematic Review.
Medicina (Kaunas)
2022
36143285
Open Innovation as the Catalyst in the Personalized Medicine to Personalized Digital Medicine Transition.
J Pers Med
2022
1 - 50 of 701
Column Actions
Search
Recommended Authors
Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year
2014
Number of shared co-authors
2
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
2
Arne Gruen
Charite-University Hospital Berlin
Career Start Year
2010
Number of shared co-authors
1
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year
2008
Number of shared co-authors
1
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year
2005
Number of shared co-authors
2
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year
2005
Number of shared co-authors
7
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year
2004
Number of shared co-authors
4
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
3
Agnieszka Namys??-Kaletka
Maria Sklodowska-Curie National Research and Institute of Oncology
Career Start Year
2003
Number of shared co-authors
1
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
1
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year
2001
Number of shared co-authors
3
Gert De Meerleer
University Hospitals Leuven
Career Start Year
1997
Number of shared co-authors
6
Coen R N Rasch
Leiden University Medical Center
Career Start Year
1997
Number of shared co-authors
11
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year
1996
Number of shared co-authors
3
Leszek Miszczyk
MSC National Research Institute of Oncology Gliwice Branch
Career Start Year
1996
Number of shared co-authors
1
Karyn A Goodman
Mount Sinai Hospital
Career Start Year
1996
Number of shared co-authors
2
Jong Hoon Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1995
Number of shared co-authors
0
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
1
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year
1994
Number of shared co-authors
3
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
5
David Joseph
Sir Charles Gairdner Hospital
Career Start Year
1990
Number of shared co-authors
3
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1990
Number of shared co-authors
4
Jeff M Michalski
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
5
Danielle Van den Weyngaert
University of Antwerp
Career Start Year
1987
Number of shared co-authors
3
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year
1987
Number of shared co-authors
4
Silvia C Formenti
Weill Cornell Medical College
Career Start Year
1986
Number of shared co-authors
1
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
2
Andre Konski
Chester County Hospital
Career Start Year
1982
Number of shared co-authors
4
James W Denham
University of Newcastle
Career Start Year
1980
Number of shared co-authors
4
Michel Bolla
universite Grenoble-Alpes (UGA)
Career Start Year
1971
Number of shared co-authors
5
row(s) 1 - 30 of 30
Collaborators
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers
18
Philippe Lambin
Maastricht University
Co-authored papers
18
Andre Dekker
Maastricht University Medical Centre
Co-authored papers
17
Ruud G P M van Stiphout
University of Oxford
Co-authored papers
12
Bengt Glimelius
Uppsala University
Co-authored papers
12
Pierluigi Granone
Catholic University
Co-authored papers
5
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers
4
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers
4
Yingli Yang
Ruijin Hospital
Co-authored papers
3
Rafael Mart??nez-Monge
Clinica Universitaria de Navarra
Co-authored papers
3
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers
3
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers
3
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers
3
Emmanouil Fokas
Universityhospital Frankfurt
Co-authored papers
3
Cary Oberije
Maastricht University Medical Centre
Co-authored papers
2
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers
2
Hugo J W L Aerts
Harvard Medical School
Co-authored papers
2
Laurence Collette
Belgium International Drug Development Institute
Co-authored papers
2
Charles Auffray
European Institute for Systems Biology and Medicine
Co-authored papers
2
Alessandro Repici
Co-authored papers
2
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers
2
Dirk De Ruysscher
Maastro Clinic
Co-authored papers
2
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers
2
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers
2
Georgi Nalbantov
Department of Radiation Oncology (MAASTRO Clinic)
Co-authored papers
2
Christos Davatzikos
University of Pennsylvania
Co-authored papers
1
Thomas E Carey
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers
1
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
1
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers
1
Mathieu Hatt
INSERM
Co-authored papers
1
1 - 30